Theravance Biopharma Depreciation Expense (Quarterly) Trends

Theravance Biopharma, Inc. (TBPH)

19.66 +0.23 (+1.18%) USD | NASDAQ | Feb 20, 16:00

19.69 +0.03 (+0.15%) After-Hours: 20:00

Depreciation Expense (Quarterly) Chart

View Depreciation Expense (Quarterly) for TBPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Depreciation Expense (Quarterly) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Depreciation Definition

View Depreciation Definition

Start Trial

Depreciation occurs when an item experiences a loss of value. In accounting, depreciation is a non-cash expense that reduces the value of an asset. Depreciation can occur as a result of age, general use, or obsolescence.

Read full definition.

Depreciation Expense (Quarterly) Range, Past 5 Years

View Depreciation Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Depreciation Expense (Quarterly) Benchmarks

View Depreciation Expense (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	Upgrade
Nektar Therapeutics	--
Innoviva, Inc.	--
Oramed Pharmaceuticals, Inc.	Upgrade
Moderna, Inc.	--